REAC再生内源生物电细胞重编程对MCF7乳腺癌细胞的影响
Vania Fontani1,2,3, Sara Cruciani3,4, Sara Santaniello3
1Department of Regenerative Medicine, Rinaldi Fontani Institute, 50144 Florence, Italy.
Journal of personalized medicine
|June 28, 2023
概括
无线电不对称输送器 (REAC) 再生 (RGN) 治疗有效地减少了人类乳腺腺癌细胞的增殖. 这种创新方法可以通过诱导自和调节关键瘤生物标志物来帮助未来的乳腺癌疗法.
科学领域:
- 在瘤学瘤学.
- 生物技术是生物技术.
- 细胞生物学 细胞生物学
背景情况:
- 人类乳腺腺癌是一种转移性癌症,治疗选择有限.
- 化疗组合针对多种癌细胞复制机制.
- 无线电不对称传送器 (REAC) 技术提供了创新的细胞重编程和衰老对抗.
研究的目的:
- 研究REAC再生治疗对MCF-7乳腺癌细胞的影响.
- 分析REAC RGN对细胞活力,增殖和衰老的影响.
- 评估瘤进展生物标志物DKK1和SFRP1.1的调节.
主要方法:
- 用REAC RGN对MCF-7细胞进行3-7天的治疗.
- 细胞活力评估使用试蓝色试验.
- 基因和蛋白质表达通过实时qPCR和共聚焦显微镜分析.
- 通过ELISA测量DKK1和SFRP1水平;通过β-银酸酶测试测量衰老.
主要成果:
- REAC RGN治疗抵消了MCF-7细胞的增殖.
- 有证据表明,REAC RGN通过Beclin-1和LC3-I上调来诱导自.
- 瘤原生生物标志物DKK1和SFRP1被治疗调节.
结论:
- REAC RGN 在抑制乳腺癌细胞生长方面表现出潜力.
- 该机制可能涉及诱导的自和生物标志物调制.
- 进一步的体内研究是有必要的,以探索REAC RGN作为辅助癌症治疗.
相关概念视频
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
Introduction to Nuclear Reprogramming
2.0K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
2.0K


